After the DM rats were treated with nanoparticle-encapsulated curcumin, the ratio of the p-AKT to AKT IODs was significantly decreased compared with that in the untreated DM rats (p < 0.01; Figures 7A,C). This evidence concerns the gene AKT1 and diabetes mellitus.